Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock

Автор: Science Communication Lab

Загружено: 2017-11-20

Просмотров: 4826

Описание:

https://www.ibiology.org/human-diseas...

Overview
In the first of his two talks, Ted Yednock begins with an overview of multiple sclerosis. He describes how, in MS, immune cells are able to transverse the wall of blood vessels and infiltrate the brain and central nervous system resulting in damage to the myelin surrounding neurons. Yednock and his colleagues hypothesized that by blocking the infiltration of immune cells into the brain, the progression of the disease might be slowed. They went on to identify 4 integrin as the molecule that mediates adhesion of immune cells to the blood vessel wall, and they found that an 4 integrin antibody (Natalizumab or Tysabri) could block infiltration of the blood cells into the brain in a animal model of MS. Yednock then details the clinical development of Tysabri through to its approval by the FDA in 2004.
Just a few months after Tysabri was approved for MS treatment, two patients developed progressive multifocal leukoencephalopathy (PML), a fatal or seriously debilitating disease. In his second talk, Yednock describes the response of medical and regulatory groups and researchers to this discovery and its impact on the treatment of MS patients with Natalizumab/Tysabri.

About Ted Yednock
Dr. Yednock recently joined the Drug Advisory Board of the Myelin Repair Foundation, a nonprofit organization focused on the discovery and development of therapeutics for multiple sclerosis (MS). Previously Dr. Yednock was the Executive Vice President and Head of Global Research for Elan Pharmaceuticals and a scientist at Athena Neurosciences. Through his scientific work at Athena, Yednock invented Tysabri (Natalizumab), a monoclonal antibody therapeutic that was approved by the FDA, in 2004, for the treatment of MS. He continued to support the program from a scientific perspective as it moved through development for MS at Elan and later in collaboration with Biogen-Idec. In addition to his work with the Myelin Repair Foundation, Yednock is also a scientific advisor to several companies and start-ups.
Yednock was an undergraduate student at the University of Illinois, Champaign-Urbana. He received his PhD in anatomy and cell biology from the University of California, San Francisco where he was also a post-doctoral fellow.

Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

array(20) { ["hQfoSj2fcxk"]=> object(stdClass)#7730 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "hQfoSj2fcxk" ["related_video_title"]=> string(70) "Bench to Bedside: Multiple Sclerosis and Tysabri, Part 2 - Ted Yednock" ["posted_time"]=> string(19) "7 лет назад" ["channelName"]=> NULL } ["hEFdVPkQfJk"]=> object(stdClass)#7734 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "hEFdVPkQfJk" ["related_video_title"]=> string(99) "Bench to Bedside: Myelination 1 - Myelination, Remyelination and Multiple Sclerosis - Mikael Simons" ["posted_time"]=> string(19) "7 лет назад" ["channelName"]=> NULL } ["-ucjHpjlvQo"]=> object(stdClass)#7728 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "-ucjHpjlvQo" ["related_video_title"]=> string(73) "Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan" ["posted_time"]=> string(19) "1 год назад" ["channelName"]=> NULL } ["N1I2SUm7IOw"]=> object(stdClass)#7738 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "N1I2SUm7IOw" ["related_video_title"]=> string(93) "Bench to Bedside: Myelination 2 - Neuropathology of Multiple Sclerosis - Christine Stadelmann" ["posted_time"]=> string(19) "7 лет назад" ["channelName"]=> NULL } ["i6d-b6VTH5w"]=> object(stdClass)#7722 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "i6d-b6VTH5w" ["related_video_title"]=> string(66) "Tyruko Vs. Tysabri for Multiple Sclerosis Explained by Neurologist" ["posted_time"]=> string(21) "2 года назад" ["channelName"]=> NULL } ["N5f_tzoA2oE"]=> object(stdClass)#7739 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "N5f_tzoA2oE" ["related_video_title"]=> string(42) "Редакция News: 195-я неделя" ["posted_time"]=> string(21) "3 часа назад" ["channelName"]=> NULL } ["C-xMgzCpiGE"]=> object(stdClass)#7726 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "C-xMgzCpiGE" ["related_video_title"]=> string(99) "Тисабри, Окревус и Лемтрада! О боже! Обновления 2019 года" ["posted_time"]=> string(19) "6 лет назад" ["channelName"]=> NULL } ["Otf1l6jrNaQ"]=> object(stdClass)#7733 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "Otf1l6jrNaQ" ["related_video_title"]=> string(89) "Improving quality of life for Multiple Sclerosis patients | Christopher Patrick | TEDxCSU" ["posted_time"]=> string(19) "1 год назад" ["channelName"]=> NULL } ["JPlOwCRpVvA"]=> object(stdClass)#7716 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "JPlOwCRpVvA" ["related_video_title"]=> string(68) "Bench to Bedside: Drug Discovery in Neuroscience - Ricardo Dolmetsch" ["posted_time"]=> string(19) "7 лет назад" ["channelName"]=> NULL } ["ScaY3P2UOz8"]=> object(stdClass)#7741 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "ScaY3P2UOz8" ["related_video_title"]=> string(124) "Понимание рассеянного склероза (Рассеянный склероз с объяснениями)" ["posted_time"]=> string(21) "2 года назад" ["channelName"]=> NULL } ["fu0tuD4E6as"]=> object(stdClass)#7729 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "fu0tuD4E6as" ["related_video_title"]=> string(43) "Tysabri PML Risk & Extended Interval Dosing" ["posted_time"]=> string(21) "3 года назад" ["channelName"]=> NULL } ["s2hxb5vCN74"]=> object(stdClass)#7735 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "s2hxb5vCN74" ["related_video_title"]=> string(72) "MS and Fatigue: Tired of Being Tired - Ben Thrower, M.D. - November 2015" ["posted_time"]=> string(19) "9 лет назад" ["channelName"]=> NULL } ["n973grL6kLo"]=> object(stdClass)#7723 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "n973grL6kLo" ["related_video_title"]=> string(72) "Bench to Bedside: Genetics of Circadian Rhythms, Part 1 - Louis Ptáček" ["posted_time"]=> string(19) "7 лет назад" ["channelName"]=> NULL } ["HD2QGCu-GIk"]=> object(stdClass)#7721 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "HD2QGCu-GIk" ["related_video_title"]=> string(76) "Beth Stevens (Boston Children’s) 1: Microglia States in Health and Disease" ["posted_time"]=> string(19) "5 лет назад" ["channelName"]=> NULL } ["5BuL5o13_u4"]=> object(stdClass)#7719 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "5BuL5o13_u4" ["related_video_title"]=> string(69) "8/10 Remyelination in multiple sclerosis | Professor Gavin Giovannoni" ["posted_time"]=> string(19) "6 лет назад" ["channelName"]=> NULL } ["C0mvrES56rM"]=> object(stdClass)#7720 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "C0mvrES56rM" ["related_video_title"]=> string(92) "B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape" ["posted_time"]=> string(21) "4 года назад" ["channelName"]=> NULL } ["BvXEtaF7XB0"]=> object(stdClass)#7717 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "BvXEtaF7XB0" ["related_video_title"]=> string(134) "Разборки лекарств от рассеянного склероза: какие лекарства самые лучшие?" ["posted_time"]=> string(21) "2 года назад" ["channelName"]=> NULL } ["Re8nFuSTh-0"]=> object(stdClass)#7718 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "Re8nFuSTh-0" ["related_video_title"]=> string(69) "Multiple sclerosis: the missing link: Renaud du Pasquier at TEDxCHUV" ["posted_time"]=> string(20) "13 лет назад" ["channelName"]=> NULL } ["Jw_y3Qlzl3c"]=> object(stdClass)#7706 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "Jw_y3Qlzl3c" ["related_video_title"]=> string(55) "Remyelination for Multiple Sclerosis, Luke Lairson, PhD" ["posted_time"]=> string(19) "6 лет назад" ["channelName"]=> NULL } ["1Eihr3X2EVY"]=> object(stdClass)#7707 (5) { ["video_id"]=> int(9999999) ["related_video_id"]=> string(11) "1Eihr3X2EVY" ["related_video_title"]=> string(0) "" ["posted_time"]=> string(19) "9 лет назад" ["channelName"]=> NULL } }
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 2 - Ted Yednock

Bench to Bedside: Multiple Sclerosis and Tysabri, Part 2 - Ted Yednock

Bench to Bedside: Myelination 1 - Myelination, Remyelination and Multiple Sclerosis - Mikael Simons

Bench to Bedside: Myelination 1 - Myelination, Remyelination and Multiple Sclerosis - Mikael Simons

Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan

Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan

Bench to Bedside: Myelination 2 - Neuropathology of Multiple Sclerosis - Christine Stadelmann

Bench to Bedside: Myelination 2 - Neuropathology of Multiple Sclerosis - Christine Stadelmann

Tyruko Vs. Tysabri for Multiple Sclerosis Explained by Neurologist

Tyruko Vs. Tysabri for Multiple Sclerosis Explained by Neurologist

Редакция News: 195-я неделя

Редакция News: 195-я неделя

Тисабри, Окревус и Лемтрада! О боже! Обновления 2019 года

Тисабри, Окревус и Лемтрада! О боже! Обновления 2019 года

Improving quality of life for Multiple Sclerosis patients | Christopher Patrick | TEDxCSU

Improving quality of life for Multiple Sclerosis patients | Christopher Patrick | TEDxCSU

Bench to Bedside: Drug Discovery in Neuroscience - Ricardo Dolmetsch

Bench to Bedside: Drug Discovery in Neuroscience - Ricardo Dolmetsch

Понимание рассеянного склероза (Рассеянный склероз с объяснениями)

Понимание рассеянного склероза (Рассеянный склероз с объяснениями)

Tysabri PML Risk & Extended Interval Dosing

Tysabri PML Risk & Extended Interval Dosing

MS and Fatigue: Tired of Being Tired - Ben Thrower, M.D. - November 2015

MS and Fatigue: Tired of Being Tired - Ben Thrower, M.D. - November 2015

Bench to Bedside: Genetics of Circadian Rhythms, Part 1 - Louis Ptáček

Bench to Bedside: Genetics of Circadian Rhythms, Part 1 - Louis Ptáček

Beth Stevens (Boston Children’s) 1: Microglia States in Health and Disease

Beth Stevens (Boston Children’s) 1: Microglia States in Health and Disease

8/10 Remyelination in multiple sclerosis | Professor Gavin Giovannoni

8/10 Remyelination in multiple sclerosis | Professor Gavin Giovannoni

B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape

B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape

Разборки лекарств от рассеянного склероза: какие лекарства самые лучшие?

Разборки лекарств от рассеянного склероза: какие лекарства самые лучшие?

Multiple sclerosis: the missing link: Renaud du Pasquier at TEDxCHUV

Multiple sclerosis: the missing link: Renaud du Pasquier at TEDxCHUV

Remyelination for Multiple Sclerosis, Luke Lairson, PhD

Remyelination for Multiple Sclerosis, Luke Lairson, PhD

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]